| Literature DB >> 30243072 |
Bo Wu1, Yunting Du2, Yonghui Feng3, Qinghui Wang2, Wei Pang2, Zanmei Qi2, Jichun Wang4, Dan Yang5, Yang Liu5, Yaming Cao6.
Abstract
Cerebral malaria (CM) is a serious and fatal malaria-associated syndrome caused by the development of an overwhelming proinflammatory response. Vitamin D (Vit.D; cholecalciferol) has regulatory functions associated with both innate and adaptive immune responses. Prevention is better than cure, in this experiment, we evaluated prophylactic oral Vit.D as a means of preventing CM presentation before infection of C57BL/6 mice with Plasmodium berghei ANKA (PbA) by modulating the host proinflammatory response. Mice that were supplemented with oral Vit.D has reduce death rate and ameliorated the integrity of the blood brain barrier. Prophylactic oral vitamin D relieved the symptoms of brain malaria and avoided death, gained valuable time for the diagnosis and treatment post infection. The robust Th1 response was attenuated in the Vit.D + PbA group. Furthermore, T-cell trafficking to the brain was diminished before PbA infection using Vit.D. The results suggest that Vit.D supplementation mediates the development of an anti-inflammatory environment that improves CM severity. In summary, the use of Vit.D as a nutritional supplement in malaria-endemic regions may help reduce the severity and mortality of CM.Entities:
Keywords: C57BL/6 mice; Cerebral malaria; Plasmodijum berghei; Vitamin D
Mesh:
Substances:
Year: 2018 PMID: 30243072 DOI: 10.1016/j.intimp.2018.08.041
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932